狭心症の薬の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)

【英語タイトル】Global Angina Pectoris Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

GlobalInfoResearchが出版した調査資料(GIR8100183)・商品コード:GIR8100183
・発行会社(調査会社):GlobalInfoResearch
・発行日:2018年9月27日
・ページ数:119
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:世界
・産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥365,400見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥548,100見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥730,800見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは、狭心症の薬の世界市場について調べ、まとめました。種類別セグメントは、ベータブロッカー、カルシウム拮抗薬、抗凝固剤、抗血小板、その他等、用途別セグメントは、病院、診療所、外来手術センター等に区分しました。狭心症の薬の世界市場概観、メーカー動向、メーカー別狭心症の薬シェア、市場規模推移、市場規模予測、主要地域分析(北米、ヨーロッパ、アジア等)、主要国分析(日本、中国、アメリカ等)データなどの情報が含まれています。
・狭心症の薬の市場概観
・狭心症の薬のメーカー概要(事業概要、製品種類、価格、売上、市場シェア等)
・狭心症の薬のメーカー別販売動向、市場シェア、市場集中度、競争動向
・狭心症の薬の世界市場規模
・狭心症の薬の北米市場分析(アメリカ、カナダ、メキシコ等)
・狭心症の薬のアメリカ市場規模推移
・狭心症の薬のカナダ市場規模推移
・狭心症の薬のメキシコ市場規模推移
・狭心症の薬のヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・狭心症の薬のドイツ市場規模推移
・狭心症の薬のイギリス市場規模推移
・狭心症の薬のロシア市場規模推移
・狭心症の薬のアジア市場分析(日本、中国、韓国、インド、東南アジア等)
・狭心症の薬の日本市場規模推移
・狭心症の薬の中国市場規模推移
・狭心症の薬の韓国市場規模推移
・狭心症の薬のインド市場規模推移
・狭心症の薬の東南アジア市場規模推移
・狭心症の薬の南米市場分析(ブラジル、アルゼンチン等)
・狭心症の薬の中東・アフリカ市場分析(サウジアラビア、UAE、南アフリカ等)
・狭心症の薬の種類別分析/市場規模推移(ベータブロッカー、カルシウム拮抗薬、抗凝固剤、抗血小板、その他)
・狭心症の薬の用途別分析/市場規模推移(病院、診療所、外来手術センター)
・狭心症の薬の市場予測(地域別予測、種類別予測、用途別予測)
・狭心症の薬の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Angina pectoris is a clinical indication characterized by precordial heaviness or discomfort due to transient myocardial ischemia without infarction, elicited by physical exertion or psychological stress. Angina pectoris is categorized as – stable, unstable, microvascular and Prinzmetal / variant. Angina pectoris is an initial presentation of coronary heart disease (CHD) and exerts a major impact on quality of life (QOL), costs to the society and ability to work.

Scope of the Report:

This report focuses on the Angina Pectoris Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Chronic stable angina pectoris has a prevalence of 2.0 – 4.0% in the seven major markets (U.S., U.K., Germany, France, Italy, Spain, Japan). Heart Disease and Stroke Statistics from American Heart Association estimates indicate that over nine million adults in the U.S. have chronic angina pectoris.

The worldwide market for Angina Pectoris Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Pfizer

Bayer

AstraZeneca

Gilead

Novartis

GlaxoSmithKline

Merck

Mylan

Teva Pharmaceutical

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Beta Blockers

Calcium Antagonists

Anticoagulants

Anti-Platelets

Others

Market Segment by Applications, can be divided into

Hospitals

Clinics

ASCs

There are 15 Chapters to deeply display the global Angina Pectoris Drugs market.

Chapter 1, to describe Angina Pectoris Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Angina Pectoris Drugs, with sales, revenue, and price of Angina Pectoris Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Angina Pectoris Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Angina Pectoris Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Angina Pectoris Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

【レポートの目次】

Table of Contents

1 Market Overview

1.1 Angina Pectoris Drugs Introduction

1.2 Market Analysis by Type

1.2.1 Beta Blockers

1.2.2 Calcium Antagonists

1.2.3 Anticoagulants

1.2.4 Anti-Platelets

1.2.5 Others

1.3 Market Analysis by Applications

1.3.1 Hospitals

1.3.2 Clinics

1.3.3 ASCs

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Pfizer

2.1.1 Business Overview

2.1.2 Angina Pectoris Drugs Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Pfizer Angina Pectoris Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Bayer

2.2.1 Business Overview

2.2.2 Angina Pectoris Drugs Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Bayer Angina Pectoris Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 AstraZeneca

2.3.1 Business Overview

2.3.2 Angina Pectoris Drugs Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 AstraZeneca Angina Pectoris Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Gilead

2.4.1 Business Overview

2.4.2 Angina Pectoris Drugs Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Gilead Angina Pectoris Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Novartis

2.5.1 Business Overview

2.5.2 Angina Pectoris Drugs Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Novartis Angina Pectoris Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 GlaxoSmithKline

2.6.1 Business Overview

2.6.2 Angina Pectoris Drugs Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 GlaxoSmithKline Angina Pectoris Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Merck

2.7.1 Business Overview

2.7.2 Angina Pectoris Drugs Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Merck Angina Pectoris Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Mylan

2.8.1 Business Overview

2.8.2 Angina Pectoris Drugs Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Mylan Angina Pectoris Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Teva Pharmaceutical

2.9.1 Business Overview

2.9.2 Angina Pectoris Drugs Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Teva Pharmaceutical Angina Pectoris Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Angina Pectoris Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Angina Pectoris Drugs Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Angina Pectoris Drugs Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Angina Pectoris Drugs Manufacturer Market Share in 2017

3.3.2 Top 6 Angina Pectoris Drugs Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Angina Pectoris Drugs Market Analysis by Regions

4.1 Global Angina Pectoris Drugs Sales, Revenue and Market Share by Regions

4.1.1 Global Angina Pectoris Drugs Sales and Market Share by Regions (2013-2018)

4.1.2 Global Angina Pectoris Drugs Revenue and Market Share by Regions (2013-2018)

4.2 North America Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

4.3 Europe Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

4.5 South America Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

5 North America Angina Pectoris Drugs by Countries

5.1 North America Angina Pectoris Drugs Sales, Revenue and Market Share by Countries

5.1.1 North America Angina Pectoris Drugs Sales and Market Share by Countries (2013-2018)

5.1.2 North America Angina Pectoris Drugs Revenue and Market Share by Countries (2013-2018)

5.2 United States Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

5.3 Canada Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

5.4 Mexico Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

6 Europe Angina Pectoris Drugs by Countries

6.1 Europe Angina Pectoris Drugs Sales, Revenue and Market Share by Countries

6.1.1 Europe Angina Pectoris Drugs Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Angina Pectoris Drugs Revenue and Market Share by Countries (2013-2018)

6.2 Germany Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

6.3 UK Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

6.4 France Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

6.5 Russia Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

6.6 Italy Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

7 Asia-Pacific Angina Pectoris Drugs by Countries

7.1 Asia-Pacific Angina Pectoris Drugs Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Angina Pectoris Drugs Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Angina Pectoris Drugs Revenue and Market Share by Countries (2013-2018)

7.2 China Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

7.3 Japan Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

7.4 Korea Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

7.5 India Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

8 South America Angina Pectoris Drugs by Countries

8.1 South America Angina Pectoris Drugs Sales, Revenue and Market Share by Countries

8.1.1 South America Angina Pectoris Drugs Sales and Market Share by Countries (2013-2018)

8.1.2 South America Angina Pectoris Drugs Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

8.3 Argentina Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

8.4 Colombia Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

9 Middle East and Africa Angina Pectoris Drugs by Countries

9.1 Middle East and Africa Angina Pectoris Drugs Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Angina Pectoris Drugs Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Angina Pectoris Drugs Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

9.3 UAE Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

9.4 Egypt Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

9.5 Nigeria Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

9.6 South Africa Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

10 Global Angina Pectoris Drugs Market Segment by Type

10.1 Global Angina Pectoris Drugs Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Angina Pectoris Drugs Sales and Market Share by Type (2013-2018)

10.1.2 Global Angina Pectoris Drugs Revenue and Market Share by Type (2013-2018)

10.2 Beta Blockers Sales Growth and Price

10.2.1 Global Beta Blockers Sales Growth (2013-2018)

10.2.2 Global Beta Blockers Price (2013-2018)

10.3 Calcium Antagonists Sales Growth and Price

10.3.1 Global Calcium Antagonists Sales Growth (2013-2018)

10.3.2 Global Calcium Antagonists Price (2013-2018)

10.4 Anticoagulants Sales Growth and Price

10.4.1 Global Anticoagulants Sales Growth (2013-2018)

10.4.2 Global Anticoagulants Price (2013-2018)

10.5 Anti-Platelets Sales Growth and Price

10.5.1 Global Anti-Platelets Sales Growth (2013-2018)

10.5.2 Global Anti-Platelets Price (2013-2018)

10.6 Others Sales Growth and Price

10.6.1 Global Others Sales Growth (2013-2018)

10.6.2 Global Others Price (2013-2018)

11 Global Angina Pectoris Drugs Market Segment by Application

11.1 Global Angina Pectoris Drugs Sales Market Share by Application (2013-2018)

11.2 Hospitals Sales Growth (2013-2018)

11.3 Clinics Sales Growth (2013-2018)

11.4 ASCs Sales Growth (2013-2018)

12 Angina Pectoris Drugs Market Forecast (2018-2023)

12.1 Global Angina Pectoris Drugs Sales, Revenue and Growth Rate (2018-2023)

12.2 Angina Pectoris Drugs Market Forecast by Regions (2018-2023)

12.2.1 North America Angina Pectoris Drugs Market Forecast (2018-2023)

12.2.2 Europe Angina Pectoris Drugs Market Forecast (2018-2023)

12.2.3 Asia-Pacific Angina Pectoris Drugs Market Forecast (2018-2023)

12.2.4 South America Angina Pectoris Drugs Market Forecast (2018-2023)

12.2.5 Middle East and Africa Angina Pectoris Drugs Market Forecast (2018-2023)

12.3 Angina Pectoris Drugs Market Forecast by Type (2018-2023)

12.3.1 Global Angina Pectoris Drugs Sales Forecast by Type (2018-2023)

12.3.2 Global Angina Pectoris Drugs Market Share Forecast by Type (2018-2023)

12.4 Angina Pectoris Drugs Market Forecast by Application (2018-2023)

12.4.1 Global Angina Pectoris Drugs Sales Forecast by Application (2018-2023)

12.4.2 Global Angina Pectoris Drugs Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures



Figure Angina Pectoris Drugs Picture

Table Product Specifications of Angina Pectoris Drugs

Figure Global Sales Market Share of Angina Pectoris Drugs by Types in 2017

Table Angina Pectoris Drugs Types for Major Manufacturers

Figure Beta Blockers Picture

Figure Calcium Antagonists Picture

Figure Anticoagulants Picture

Figure Anti-Platelets Picture

Figure Others Picture

Figure Angina Pectoris Drugs Sales Market Share by Applications in 2017

Figure Hospitals Picture

Figure Clinics Picture

Figure ASCs Picture

Figure United States Angina Pectoris Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Angina Pectoris Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Angina Pectoris Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Angina Pectoris Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure France Angina Pectoris Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure UK Angina Pectoris Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Angina Pectoris Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Angina Pectoris Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure China Angina Pectoris Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Angina Pectoris Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Angina Pectoris Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure India Angina Pectoris Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Angina Pectoris Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Angina Pectoris Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Angina Pectoris Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Angina Pectoris Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Angina Pectoris Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Angina Pectoris Drugs Revenue (Value) and Growth Rate (2013-2023)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Angina Pectoris Drugs Type and Applications

Table Pfizer Angina Pectoris Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Bayer Basic Information, Manufacturing Base and Competitors

Table Bayer Angina Pectoris Drugs Type and Applications

Table Bayer Angina Pectoris Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table AstraZeneca Basic Information, Manufacturing Base and Competitors

Table AstraZeneca Angina Pectoris Drugs Type and Applications

Table AstraZeneca Angina Pectoris Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Gilead Basic Information, Manufacturing Base and Competitors

Table Gilead Angina Pectoris Drugs Type and Applications

Table Gilead Angina Pectoris Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis Angina Pectoris Drugs Type and Applications

Table Novartis Angina Pectoris Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors

Table GlaxoSmithKline Angina Pectoris Drugs Type and Applications

Table GlaxoSmithKline Angina Pectoris Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Merck Basic Information, Manufacturing Base and Competitors

Table Merck Angina Pectoris Drugs Type and Applications

Table Merck Angina Pectoris Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Mylan Basic Information, Manufacturing Base and Competitors

Table Mylan Angina Pectoris Drugs Type and Applications

Table Mylan Angina Pectoris Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table Teva Pharmaceutical Angina Pectoris Drugs Type and Applications

Table Teva Pharmaceutical Angina Pectoris Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Angina Pectoris Drugs Sales by Manufacturer (2016-2017)

Figure Global Angina Pectoris Drugs Sales Market Share by Manufacturer in 2016

Figure Global Angina Pectoris Drugs Sales Market Share by Manufacturer in 2017

Table Global Angina Pectoris Drugs Revenue by Manufacturer (2016-2017)

Figure Global Angina Pectoris Drugs Revenue Market Share by Manufacturer in 2016

Figure Global Angina Pectoris Drugs Revenue Market Share by Manufacturer in 2017

Figure Top 3 Angina Pectoris Drugs Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Angina Pectoris Drugs Manufacturer (Revenue) Market Share in 2017

Figure Global Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

Figure Global Angina Pectoris Drugs Revenue and Growth Rate (2013-2018)

Table Global Angina Pectoris Drugs Sales by Regions (2013-2018)

Table Global Angina Pectoris Drugs Sales Market Share by Regions (2013-2018)

Table Global Angina Pectoris Drugs Revenue by Regions (2013-2018)

Figure Global Angina Pectoris Drugs Revenue Market Share by Regions in 2013

Figure Global Angina Pectoris Drugs Revenue Market Share by Regions in 2017

Figure North America Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

Figure Europe Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

Figure South America Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

Figure North America Angina Pectoris Drugs Revenue and Growth Rate (2013-2018)

Table North America Angina Pectoris Drugs Sales by Countries (2013-2018)

Table North America Angina Pectoris Drugs Sales Market Share by Countries (2013-2018)

Figure North America Angina Pectoris Drugs Sales Market Share by Countries in 2013

Figure North America Angina Pectoris Drugs Sales Market Share by Countries in 2017

Table North America Angina Pectoris Drugs Revenue by Countries (2013-2018)

Table North America Angina Pectoris Drugs Revenue Market Share by Countries (2013-2018)

Figure North America Angina Pectoris Drugs Revenue Market Share by Countries in 2013

Figure North America Angina Pectoris Drugs Revenue Market Share by Countries in 2017

Figure United States Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

Figure Canada Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

Figure Mexico Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

Figure Europe Angina Pectoris Drugs Revenue and Growth Rate (2013-2018)

Table Europe Angina Pectoris Drugs Sales by Countries (2013-2018)

Table Europe Angina Pectoris Drugs Sales Market Share by Countries (2013-2018)

Table Europe Angina Pectoris Drugs Revenue by Countries (2013-2018)

Figure Europe Angina Pectoris Drugs Revenue Market Share by Countries in 2016

Figure Europe Angina Pectoris Drugs Revenue Market Share by Countries in 2017

Figure Germany Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

Figure UK Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

Figure France Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

Figure Russia Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

Figure Italy Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Angina Pectoris Drugs Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Angina Pectoris Drugs Sales by Countries (2013-2018)

Table Asia-Pacific Angina Pectoris Drugs Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Angina Pectoris Drugs Sales Market Share by Countries 2017

Table Asia-Pacific Angina Pectoris Drugs Revenue by Countries (2013-2018)

Figure Asia-Pacific Angina Pectoris Drugs Revenue Market Share by Countries 2017

Figure China Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

Figure Japan Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

Figure Korea Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

Figure India Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

Figure Southeast Asia Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

Figure South America Angina Pectoris Drugs Revenue and Growth Rate (2013-2018)

Table South America Angina Pectoris Drugs Sales by Countries (2013-2018)

Table South America Angina Pectoris Drugs Sales Market Share by Countries (2013-2018)

Figure South America Angina Pectoris Drugs Sales Market Share by Countries in 2017

Table South America Angina Pectoris Drugs Revenue by Countries (2013-2018)

Table South America Angina Pectoris Drugs Revenue Market Share by Countries (2013-2018)

Figure South America Angina Pectoris Drugs Revenue Market Share by Countries in 2017

Figure Brazil Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

Figure Argentina Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

Figure Colombia Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Angina Pectoris Drugs Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Angina Pectoris Drugs Sales by Countries (2013-2018)

Table Middle East and Africa Angina Pectoris Drugs Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Angina Pectoris Drugs Sales Market Share by Countries in 2017

Table Middle East and Africa Angina Pectoris Drugs Revenue by Countries (2013-2018)

Table Middle East and Africa Angina Pectoris Drugs Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Angina Pectoris Drugs Revenue Market Share by Countries in 2013

Figure Middle East and Africa Angina Pectoris Drugs Revenue Market Share by Countries in 2017

Figure Saudi Arabia Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

Figure UAE Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

Figure Egypt Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

Figure Nigeria Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

Figure South Africa Angina Pectoris Drugs Sales and Growth Rate (2013-2018)

Table Global Angina Pectoris Drugs Sales by Type (2013-2018)

Table Global Angina Pectoris Drugs Sales Share by Type (2013-2018)

Table Global Angina Pectoris Drugs Revenue by Type (2013-2018)

Table Global Angina Pectoris Drugs Revenue Share by Type (2013-2018)

Figure Global Beta Blockers Sales Growth (2013-2018)

Figure Global Beta Blockers Price (2013-2018)

Figure Global Calcium Antagonists Sales Growth (2013-2018)

Figure Global Calcium Antagonists Price (2013-2018)

Figure Global Anticoagulants Sales Growth (2013-2018)

Figure Global Anticoagulants Price (2013-2018)

Figure Global Anti-Platelets Sales Growth (2013-2018)

Figure Global Anti-Platelets Price (2013-2018)

Figure Global Others Sales Growth (2013-2018)

Figure Global Others Price (2013-2018)

Table Global Angina Pectoris Drugs Sales by Application (2013-2018)

Table Global Angina Pectoris Drugs Sales Share by Application (2013-2018)

Figure Global Clinics Sales Growth (2013-2018)

Figure Global ASCs Sales Growth (2013-2018)

Figure Global Angina Pectoris Drugs Sales, Revenue and Growth Rate (2018-2023)

Table Global Angina Pectoris Drugs Sales Forecast by Regions (2018-2023)

Table Global Angina Pectoris Drugs Market Share Forecast by Regions (2018-2023)

Figure North America Sales Angina Pectoris Drugs Market Forecast (2018-2023)

Figure Europe Sales Angina Pectoris Drugs Market Forecast (2018-2023)

Figure Asia-Pacific Sales Angina Pectoris Drugs Market Forecast (2018-2023)

Figure South America Sales Angina Pectoris Drugs Market Forecast (2018-2023)

Figure Middle East and Africa Sales Angina Pectoris Drugs Market Forecast (2018-2023)

Table Global Angina Pectoris Drugs Sales Forecast by Type (2018-2023)

Table Global Angina Pectoris Drugs Market Share Forecast by Type (2018-2023)

Table Global Angina Pectoris Drugs Sales Forecast by Application (2018-2023)

Table Global Angina Pectoris Drugs Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List



【レポートのキーワード】

狭心症の薬、ベータブロッカー、カルシウム拮抗薬、抗凝固剤、抗血小板、その他、病院、診療所、外来手術センター

★調査レポート[狭心症の薬の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)] (コード:GIR8100183)販売に関する免責事項を必ずご確認ください。
★調査レポート[狭心症の薬の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆